MESTRONI, LUISA
 Distribuzione geografica
Continente #
NA - Nord America 7.467
EU - Europa 4.346
AS - Asia 3.629
SA - Sud America 455
Continente sconosciuto - Info sul continente non disponibili 453
AF - Africa 107
OC - Oceania 6
Totale 16.463
Nazione #
US - Stati Uniti d'America 7.305
SG - Singapore 1.332
PL - Polonia 1.265
IT - Italia 1.146
CN - Cina 797
VN - Vietnam 368
SE - Svezia 349
BR - Brasile 347
HK - Hong Kong 337
DE - Germania 294
BD - Bangladesh 236
FR - Francia 224
NL - Olanda 188
GB - Regno Unito 174
KR - Corea 174
FI - Finlandia 152
RU - Federazione Russa 117
UA - Ucraina 102
CA - Canada 84
IN - India 81
TR - Turchia 79
BG - Bulgaria 72
IE - Irlanda 72
JP - Giappone 40
AR - Argentina 38
CH - Svizzera 33
MX - Messico 33
MA - Marocco 32
ES - Italia 29
BE - Belgio 25
ID - Indonesia 25
ZA - Sudafrica 25
AT - Austria 20
IQ - Iraq 19
SA - Arabia Saudita 18
PK - Pakistan 17
EC - Ecuador 15
CL - Cile 12
IR - Iran 12
VE - Venezuela 12
AE - Emirati Arabi Uniti 11
CO - Colombia 11
RS - Serbia 11
JM - Giamaica 9
GR - Grecia 8
JO - Giordania 8
KG - Kirghizistan 8
PH - Filippine 8
RO - Romania 8
TN - Tunisia 8
KE - Kenya 7
MY - Malesia 7
NP - Nepal 7
PT - Portogallo 7
CR - Costa Rica 6
DZ - Algeria 6
EG - Egitto 6
IL - Israele 6
LT - Lituania 6
SN - Senegal 6
TT - Trinidad e Tobago 6
AU - Australia 5
AZ - Azerbaigian 5
HN - Honduras 5
HU - Ungheria 5
LB - Libano 5
LV - Lettonia 5
PE - Perù 5
PY - Paraguay 5
SI - Slovenia 5
UZ - Uzbekistan 5
AL - Albania 4
AO - Angola 4
BA - Bosnia-Erzegovina 4
BO - Bolivia 4
CZ - Repubblica Ceca 4
DO - Repubblica Dominicana 4
EU - Europa 4
NG - Nigeria 4
NO - Norvegia 4
TH - Thailandia 4
UY - Uruguay 4
DK - Danimarca 3
GT - Guatemala 3
KW - Kuwait 3
TW - Taiwan 3
BH - Bahrain 2
EE - Estonia 2
GA - Gabon 2
GE - Georgia 2
KZ - Kazakistan 2
LK - Sri Lanka 2
MD - Moldavia 2
PA - Panama 2
PR - Porto Rico 2
SK - Slovacchia (Repubblica Slovacca) 2
AG - Antigua e Barbuda 1
BM - Bermuda 1
BN - Brunei Darussalam 1
BS - Bahamas 1
Totale 15.990
Città #
Warsaw 1.181
Ashburn 947
Singapore 836
Fairfield 499
Chandler 454
San Jose 361
Woodbridge 346
Hong Kong 326
Houston 285
Ann Arbor 268
Chicago 236
Wilmington 227
Beijing 218
Trieste 218
Seattle 201
Council Bluffs 188
Cambridge 185
Los Angeles 184
Seoul 162
Dallas 150
Hefei 125
Jacksonville 115
Ho Chi Minh City 112
Boardman 110
Princeton 107
Santa Clara 101
Columbus 94
Milan 90
Hanoi 82
Helsinki 79
Lauterbourg 76
New York 75
Sofia 69
Rome 68
Dublin 67
Zgierz 64
Munich 63
London 61
Frankfurt am Main 58
Salt Lake City 52
Buffalo 49
Izmir 49
Moscow 48
Phoenix 48
São Paulo 41
Amsterdam 40
Dearborn 40
The Dalles 38
Dong Ket 30
San Diego 30
Tokyo 30
Redwood City 29
Atlanta 28
Düsseldorf 28
Nuremberg 28
Elk Grove Village 27
Tampa 27
Guangzhou 25
Lappeenranta 25
Brussels 24
Orem 23
Redondo Beach 23
Toronto 22
Turku 22
Bremen 21
Miano 21
Bern 20
Casablanca 20
Falls Church 20
Miami 20
Turin 20
Memphis 19
Naples 19
Da Nang 18
Denver 18
Redmond 18
Washington 18
Lancaster 17
Poplar 17
Shanghai 17
Sterling 17
Bari 16
Grafing 16
Bologna 15
Venice 15
Brooklyn 14
Chennai 14
Johannesburg 14
Montreal 14
Nanjing 14
Palermo 14
Philadelphia 14
Vienna 14
North Bergen 13
Stockholm 13
San Francisco 12
Bexley 11
Boydton 11
Des Moines 11
Florence 11
Totale 10.490
Nome #
Current understanding of the role of cytoskeletal cross-linkers in the onset and development of cardiomyopathies 524
A Review of the Giant Protein Titin in Clinical Molecular Diagnostics of Cardiomyopathies 515
Natural History of Dilated Cardiomyopathy in Children 442
Role of Titin Missense Variants in Dilated Cardiomyopathy 432
Inquadramento e gestione delle cardiomiopatie: il protocollo della Cardiologia di Trieste 421
Filamin C Truncation Mutations Are Associated With Arrhythmogenic Dilated Cardiomyopathy and Changes in the Cell–Cell Adhesion Structures 413
Improving cardiac myocytes performance by carbon nanotubes platforms 397
FLNC Gene Splice Mutations Cause Dilated Cardiomyopathy 394
Knock Down of Plakophillin 2 Dysregulates Adhesion Pathway through Upregulation of miR200b and Alters the Mechanical Properties in Cardiac Cells 338
Altered microtubule structure, hemichannel localization and beating activity in cardiomyocytes expressing pathologic nuclear lamin A/C 296
Cellular biomechanics impairment in keratinocytes is associated with a C-terminal truncated desmoplakin: An atomic force microscopy investigation 295
Biomechanical defects and rescue of cardiomyocytes expressing pathologic nuclear lamins 293
Historical Terminology, Classifications, and Present Definition of DCM. 282
The giant protein Titin’s role in cardiomyopathy: genetic, transcriptional, and post translational modifications of TTN and their contribution to cardiac disease 276
Easy fabrication of aligned PLLA nanofibers-based 2D scaffolds suitable for cell contact guidance studies 264
Carbon nanotube facilitation of myocardial ablation with radiofrequency energy 263
Chapter 5: Genetics of Dilated Cardiomyopathy: Current Knowledge and Future Perspectives 263
Genetics of Dilated Cardiomyopathy: Clinical Implications 254
Phenotypic Expression, Natural History and Risk Stratification of Cardiomyopathy Caused by Filamin C Truncating Variants 242
Titin and desmosomal genes in the natural history of arrhythmogenic right ventricular cardiomyopathy 238
Genetic and Phenotypic Characterization of Nexilin (NEXN)-Related Cardiomyopathy: Results From a Multicentric Study 238
Arrhythmogenic right ventricular cardiomyopathy: Arrhythmogenic right ventricular cardiomyopathy: Clinical assessment and differential diagnosis 237
The role of clinical observation: Red flag 6-left ventricular non-compaction 236
Regional Variation in RBM20 Causes a Highly Penetrant Arrhythmogenic Cardiomyopathy 232
The role of clinical observation: Red flag 7-syndromic and multi-system cardiomyopathies 228
Association of Titin Variations with Late-Onset Dilated Cardiomyopathy 227
Prevalence and evolution of right ventricular dysfunction among different genetic backgrounds in dilated cardiomyopathy 226
Contemporary survival trends and aetiological characterization in non-ischaemic dilated cardiomyopathy 220
Clinical Risk Score to Predict Pathogenic Genotypes in Patients With Dilated Cardiomyopathy 213
Early Arrhythmic Events in Idiopathic Dilated Cardiomyopathy 212
Sex differences in natural history of cardiovascular magnetic resonance- and biopsy-proven lymphocytic myocarditis 197
Trattamento dello scompenso cardiaco con terapia genica: i risultati inattesi del trial CUPID 2 196
Impact of DCM-Causing Genetic Background on Long-Term Response to Cardiac Resynchronization Therapy 195
Clinical features and outcomes in carriers of pathogenic desmoplakin variants 194
Danon Disease-Associated LAMP-2 Deficiency Drives Metabolic Signature Indicative of Mitochondrial Aging and Fibrosis in Cardiac Tissue and hiPSC-Derived Cardiomyocytes 194
Antiarrhythmic therapy and risk of cumulative ventricular arrhythmias in arrhythmogenic right ventricle cardiomyopathy 193
Atomic Force Microscopy (AFM) applications in arrhythmo-genic cardiomyopathy 188
Molecular and Cellular Mechanisms in Heart Failure 187
Arrhythmic Risk Stratification of Carriers of Filamin C Truncating Variants 182
SCN5A Mutations Associate With Arrhythmic Dilated Cardiomyopathy and Commonly Localize to the Voltage-Sensing Mechanism. 179
Introduction 179
Viscoelastic behavior of cardiomyocytes carrying LMNA mutations 179
Clinical Spectrum of PRKAG2 Syndrome 176
A novel tool for arrhythmic risk stratification in desmoplakin gene variant carriers 172
Prognostic role of exercise intensity in familial Filamin C truncating variants 171
Cellular Biomechanic Impairment in Cardiomyocytes Carrying the Progeria Mutation: An Atomic Force Microscopy Investigation 170
The response to cardiac resynchronization therapy in LMNA cardiomyopathy 168
AFM macro-probes to investigate whole 3D cardiac spheroids 163
Magnetic Resonance Imaging Characterization and Clinical Outcomes of Dilated and Arrhythmogenic Left Ventricular Cardiomyopathies 162
Lamin A/C Cardiomyopathy: Implications for Treatment 154
The electrocardiogram in the diagnosis and management of patients with dilated cardiomyopathy 154
The Arrhythmic Phenotype in Cardiomyopathy 148
A Systematic Analysis of the Clinical Outcome Associated with Multiple Reclassified Desmosomal Gene Variants in Arrhythmogenic Right Ventricular Cardiomyopathy Patients 146
Carbon Nanotubes for Cardiac Applications 146
Investigations of cardiac fibrosis rheology by in vitro cardiac tissue modeling with 3D cellular spheroids 141
Microfabricated cantilevers for parallelized cell-cell adhesion measurements 141
Ankyrin-B dysfunction predisposes to arrhythmogenic cardiomyopathy and is amenable to therapy 140
Risk Stratification in Arrhythmic Right Ventricular Cardiomyopathy Without Implantable Cardioverter-Defibrillators 138
Activation of PDGFRA signaling contributes to filamin C–related arrhythmogenic cardiomyopathy 131
The genetic architecture of Plakophilin 2 cardiomyopathy 129
Arrhythmogenic right ventricular cardiomyopathy: From genetics to diagnostic and therapeutic challenges 124
CARBON NANOTUBE SCAFFOLDS FOR CARDIAC TISSUE ENGINEERING 122
null 121
Compromised Biomechanical Properties, Cell–Cell Adhesion and Nanotubes Communication in Cardiac Fibroblasts Carrying the Lamin A/C D192G Mutation 119
Titin-related familial dilated cardiomyopathy: factors associated with disease onset 118
Neonatal rat ventricular myocytes interfacing conductive polymers and carbon nanotubes 117
null 112
Gold Nanoparticle-Functionalized Reverse Thermal Gel for Tissue Engineering Applications 110
FLNC truncations cause arrhythmogenic right ventricular cardiomyopathy 110
Genetic causes of dilated cardiomyopathy 105
null 103
Multilevel analyses of SCN5A mutations in arrhythmogenic right ventricular dysplasia/cardiomyopathy suggest non-canonical mechanisms for disease pathogenesis 103
Valutazione dell’ereditarietà e analisi molecolare alla luce delle nuove linee guida europee sulla cardiomiopatia ipertrofica 103
Prediction and prognostic role of left ventricular systolic dysfunction in family screening for dilated cardiomyopathy and non-dilated left ventricular cardiomyopathy 101
The Sarcomeric Spring Protein Titin: Biophysical Properties, Molecular Mechanisms, and Genetic Mutations Associated with Heart Failure and Cardiomyopathy 101
Myocardial Recovery in Recent Onset Dilated Cardiomyopathy: Role of CDCP1 and Cardiac Fibrosis 96
Impact of genotype-phenotype associations on prognosis in dilated cardiomyopathy 85
Integrated role of cardiac magnetic resonance and genetics in predicting left ventricular reverse remodelling in dilated and non-dilated cardiomyopathy 84
Risks of Ventricular Arrhythmia and Heart Failure in Carriers of RBM20 Variants 78
Prognostic Role of Myocarditis-Like Episodes and Their Treatment in Patients With Pathogenic Desmoplakin Variants 66
Sex Differences in Prognosis of Patients With Genetic Dilated Cardiomyopathy 59
External validation of the DSP-Risk Score for prediction of clinically significant ventricular arrhythmias in primary prevention patients with desmoplakin cardiomyopathy associated genetic variants 56
Future development of arrhythmogenic risk scores in patients with heart failure and inherited dilated cardiomyopathy. A scientific statement of the Heart Failure Association of the ESC 49
Twenty-Five-Year Follow-Up of the MDDC1 Family: A LMNA Gene Variant Associated With Dilated Cardiomyopathy With Variable Skeletal Muscle Involvement 36
RBM20 Truncating Variants and Human Cardiomyopathy 25
Sex and Age Specific Genetic Risk Across the Dilated and Arrhythmogenic Cardiomyopathy Spectrum: Insights From the SHaRe Registry 15
Atrial Fibrillation in Genotyped Dilated Cardiomyopathy: Epidemiology, Risk Factors, and Outcomes: Insights From the SHaRe Registry 12
Variant Site-Specific Natural History of Titin-Induced Cardiomyopathy: An International Multicenter Registry 9
Totale 16.463
Categoria #
all - tutte 46.395
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.395


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022794 0 0 64 47 52 82 47 27 103 91 56 225
2022/20231.250 105 172 136 198 112 197 17 112 124 18 40 19
2023/2024902 58 49 66 67 73 118 143 128 18 26 93 63
2024/20252.174 24 151 200 169 183 157 119 124 270 305 238 234
2025/20266.024 865 345 541 545 481 436 726 198 539 678 393 277
2026/2027916 313 253 350 0 0 0 0 0 0 0 0 0
Totale 16.463